Sort
39,280 grants matching “leukemia”
Environmental Oxygen Transitions and Aspergillosis Disease Progression
$529,372Robert Andrew Cramer · Dartmouth College · R01 · FY2020 · AI
mRNA stability and its impact on hematopoiesis and acute leukemia
$529,332Iannis Aifantis · New York University School Of Medicine · R01 · FY2023 · CA
Enhancer Dysregulation in AML
$529,271Yali Dou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
$529,222Bruno Calabretta · Thomas Jefferson University · R01 · FY2023 · CA
ONCOGENESIS AND MYELOID TRANSCRIPTION FACTORS IN AML
$529,192Daniel G Tenen · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Genetic epidemiology of hematopoietic cell transplant outcomes
$529,190Michael R Verneris · University Of Minnesota · R01 · FY2015 · CA
Small molecule CXCR4 modulators as molecular probes for studying AML
$529,121Gary E Schiltz · Northwestern University · R01 · FY2015 · CA
Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancer
$529,087Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Arsenic Trioxide &Ascorbic Acid for Multiple Myeloma
$528,999University Of Miami School Of Medicine · R01 · FY2005 · CA
Therapeutic targeting of MDS stem cells
$528,896Amit Verma · Albert Einstein College Of Medicine · R01 · FY2020 · HL
Therapeutic targeting of MDS stem cells
$528,896Amit Verma · Albert Einstein College Of Medicine · R01 · FY2019 · HL
Therapeutic targeting of MDS stem cells
$528,896Amit Verma · Albert Einstein College Of Medicine · R01 · FY2021 · HL
Reprogramming committed blood cells to a hematopoietic stem cell fate
$528,750Derrick J. Rossi · Immune Disease Institute, Inc. · R01 · FY2011 · HL
Quality of Life of African American Cancer Survivors
$528,691University Of Illinois At Chicago · R01 · FY2001 · CA
Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia
$528,622Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2021 · CA
Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia
$528,622Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2025 · CA
EZH2 in cancer biology and novel inhibitors
$528,530Jun Qi · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Basic Research on Hematopoietic Human Stem Cells
$528,467Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia
$528,437Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2023 · CA
Activation of Proto-Oncogenes by Chromosomal Translocation
$528,207Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$528,207Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
$528,175Fabiana Perna · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA
Molecular Genetics
$528,163Carlo M Croce · University Of California, San Diego · P01 · FY2014 · CA
Biologic and Therapeutic Significance of miR-155 in AML
$528,129Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Structure, Function, and Mechanism of a Mitochondrial Chaperone
$528,090Francis T.f. Tsai · Baylor College Of Medicine · R01 · FY2021 · GM